New York, NY – January 2021: AllazoHealth announced today that William Grambley will take on the position of Chief Executive Officer after serving more than two years as Chief Operating Officer at the fast-growing healthcare AI company. Grambley will have a larger role in leading a team of business development and marketing professionals, data analysts, data scientists, and engineers and a continued focus on strategic expansion.
“William is one of the sharpest leaders in our industry,” said Clifford Jones, AllazoHealth’s founder and CTO, who worked with Grambley at CVS Health prior to establishing AllazoHealth. “He has the management experience in healthcare and medication behavior expertise to oversee our expanding customer base, including our focus on supporting pharmaceutical companies.”
Prior to joining AllazoHealth, Grambley was Vice President of Strategy at CVS Health. While there, he oversaw growth for CVS Health’s largest health plan clients and led long-term strategic planning. Grambley found his entrepreneurial hunger and desire to serve come together after discovering the profound satisfaction and shared purpose among the organization he was working with to help patients.
This passion for patient support and health outcomes manifested in Grambley’s cornerstone achievement at CVS Health, spearheading its industry-leading patient support programs, including the award-winning Pharmacy Advisor Program. Under Grambley’s leadership, Pharmacy Advisor grew from concept to serving more than 14 million patients and contributed to raising CVS Health clients’ Medicare Star Ratings to their highest levels ever.
“The theme of quality, improved patient outcomes, and innovation has permeated my career,” shares Grambley. “It’s very satisfying, knowing that there is someone who, as a result of our work, is achieving a better health outcome.”
“I am looking forward to expanding my role at AllazoHealth,” Grambley added. “Our customers are achieving transformative results using our AI platform. Given the current and increasing role of AI, I’m excited about where we’re going and leading the team to our next phase of growth.”
During his time as COO at AllazoHealth, Grambley engaged with a variety of industry customers to use the company’s advanced AI platform and expert analytical services, proven time and again to boost therapy initiation, adherence, patient engagement, and health outcomes. He will continue this work as CEO, in addition to taking on overall management of and scaling the company.